These compounds may interact with:
Phospholipase D1
Potentially involved in: kidney cancer; carcinoma; cardiomegaly; infarction, middle cerebral artery; adrenocortical carcinoma; breast cancer; breast carcinoma; colon cancer; cystic fibrosis and chronic rhinosinusitis; ependymoma; esophageal adenocarcinoma; group 4 medulloblastoma; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn); lung cancer; non primary sjogren syndrome sicca; non-small cell lung cancer; oligodendroglioma; osteosarcoma
Disease data sourced from Pharos.